Caricamento...
Kynurenine pathway dysfunction in the pathophysiology and treatment of depression: evidences from animal and human studies
Treatment-resistant depression affects up to 20% of individuals suffering from major depressive disorder (MDD). The medications currently available to treat depression, including serotonin re-uptake inhibitors (SSRIs), monoamine oxidase inhibitors (MAOIs) and tricyclic antidepressants (TCAs), fail t...
Salvato in:
| Pubblicato in: | J Psychiatr Res |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
2015
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4955923/ https://ncbi.nlm.nih.gov/pubmed/26028548 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpsychires.2015.05.007 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|